Watanabe Kenichi, Nomori Hiroaki, Ohtsuka Takashi, Naruke Tsuguo, Uno Kimiichi
Department of Thoracic Surgery Saiseikai Central Hospital.
Nihon Kokyuki Gakkai Zasshi. 2004 Sep;42(9):787-93.
A considerable number of false negative cases in FDG-PET were seen in small-cell lung cancer, despite the usefulness of this imaging modality. We investigated the correlation between FDG-PET results and the clinicopathological findings in small lung cancers less than 3 cm in size. Fifty-one consecutive cases of surgically resected small lung cancers scanned preoperatively by FDG-PET was assessed. The medical records of each case were reviewed for the maximum tumor size in the CT findings, histology, grade of differentiation, lymphatic and vascular invasion, pleural invasion, lymph node stage, serum level of carcinoembryonic antigen (CEA), and CT findings. All of the 5 cases (4 adenocarcinomas, 1 small-cell carcinoma) less than 1 cm in size were false negatives. In the 46 cases 1-3 cm in size (34 adenocarcinomas, 9 squamous sell carcinomas, 2 large sell carcinomas, 1 small cell carcinoma), false negative results were seen in 8 of 15 cases of well-differentiated adenocarcinoma (53%). In the 8 false negative cases, 1 (13%) lymphatic vessel invasion (ly), 0 (0%) vascular vessel invasion (v), 0 (0%) pleural invasion (p), 0 (0%) lymph node metastasis, 0 (0%) high serum level of CEA, and 5 (63%) cases showing ground-glass opacity on CT were observed. There were significant differences in the factors ly, v, CEA, and CT findings between the 8 false-negative cases and the 26 true positive cases with adenocarcinoma (p < 0.01-0.05). Lung cancers < 1 cm in size cannot be detected in FDG-PET. Adenocarcinomas of the lung 1-3 cm in size with false negatives in FDG-PET showed significantly less invasiveness than the true positives.
尽管FDG-PET这种成像方式有一定作用,但在小细胞肺癌中仍可见到相当数量的假阴性病例。我们研究了FDG-PET结果与直径小于3 cm的小肺癌临床病理表现之间的相关性。对51例术前经FDG-PET扫描的手术切除小肺癌连续病例进行了评估。回顾了每个病例的病历,包括CT检查结果中的最大肿瘤大小、组织学、分化程度、淋巴管和血管侵犯、胸膜侵犯、淋巴结分期、癌胚抗原(CEA)血清水平以及CT检查结果。所有5例直径小于1 cm的病例(4例腺癌,1例小细胞癌)均为假阴性。在46例直径1 - 3 cm的病例(34例腺癌、9例鳞癌、2例大细胞癌、1例小细胞癌)中,15例高分化腺癌中有8例(53%)出现假阴性结果。在这8例假阴性病例中,观察到1例(13%)有淋巴管侵犯(ly),0例(0%)有血管侵犯(v),0例(0%)有胸膜侵犯(p),0例(0%)有淋巴结转移,0例(0%)CEA血清水平升高,5例(63%)在CT上表现为磨玻璃影。8例假阴性病例与26例腺癌真阳性病例在ly、v、CEA和CT表现等因素上存在显著差异(p < 0.01 - 0.05)。FDG-PET无法检测出直径小于1 cm的肺癌。FDG-PET呈假阴性的1 - 3 cm大小的肺腺癌侵袭性明显低于真阳性病例。